Researchers are investigating the mechanisms of treatment resistance in various types of cancer, including hepatocellular carcinoma, ovarian cancer, triple-negative breast cancer, and prostate cancer. Studies have identified specific resistance mechanisms, such as those related to PARP inhibitors and trastuzumab deruxtecan, but the underlying mechanisms of resistance in some cases, like the role of cytokines in ovarian cancer, remain unclear. The findings aim to inform strategies for reversing or overcoming treatment resistance and advancing therapeutic approaches.